Latest Produce News

Red Metal is advancing a pre-feasibility study for a potential 20 Mtpa heap leach operation at Sybella, backed by encouraging Fresh Granite test work and a 5,000 metre drilling program. The company ended September with A$3.031 million in cash, equivalent to an estimated 1.9 quarters of funding at the current operating cash rate.

PTR Minerals has identified potential 15-17% heavy mineral zones for early mining at Rosewood, while testing suggests a high-quality leucoxene product may be produced without dry separation. The project also cleared key water, customer and study milestones, although the work remains preliminary and includes Inferred Resources.

Alchemy Resources has confirmed copper, lead, zinc and silver anomalism across two holes into a 750-metre IP target at Yellow Mountain. The results expand the exploration picture, but drilling disruption means most of the anomaly remains untested.

Catalyst Metals has cut FY27 production guidance to 90,000-105,000 ounces after deferring Trident and Old Highway output to FY28. The downgrade comes despite a stronger balance sheet, a 2Moz Plutonic Reserve base and A$40 million of quarterly cash generation.

OzAurum Resources has strengthened the technical case for a low-capex heap leach operation at Mulgabbie North, with column testing delivering up to 95% gold recovery. But the project’s next phase is now tied to a capital raise after cash fell to A$542,000, equivalent to just 0.8 quarters of estimated funding.

Nanollose has narrowed its microbial cellulose scale-up plan to one company-controlled Western Australian pilot facility, with all Stage 1 equipment ordered and paid for. The progress comes with a clear funding constraint: the ASX-listed biomaterials developer ended September with $758,000 in cash, equivalent to 1.41 quarters of funding at its current operating burn.

Hydralyte LLC recorded its first monthly operating profit in August, while a major cost reset cut its quarterly operating loss to US$66,900. But revenue fell 21.9%, cash narrowed to US$173,400 and the company is seeking up to A$1.4 million through a rights issue.

Pure One Corporation Limited (ASX:P1E) ended September with A$1.219 million in cash after a A$5.971 million quarterly outflow. The company reports A$7.302 million in unused financing facilities, but its stated funding coverage remains just 2.32 quarters at the latest burn rate.

OncoSil Medical enters FY27 with FDA approval for its cancer device, rising quarterly revenue and fresh institutional funding, but its U.S. opportunity still depends on reimbursement and a tightly controlled initial rollout. Cash rose to A$8.7 million after the capital raise, while operating cash use remained substantial.

Bio-Gene Technology has moved closer to two commercialisation milestones, with Qcide product work progressing in Japan and a first Flavocide regulatory submission targeted for Q2 2027. The company ended September with A$2.103 million in cash, equivalent to an estimated 2.18 quarters of funding at the quarter’s operating cash rate.

Emerald Resources delivered lower September-quarter production but generated A$112.4 million in pre-tax operating cash flow as its Cambodian mine sold gold at an average US$4,255 an ounce. The company kept FY27 guidance unchanged, advanced construction work at Dingo Range and Memot, and opened a potential US$400 million acquisition funding pathway.

Axel REE has produced its first mixed rare earth carbonate from Woolrich column-leach solutions, while expanding the Caladão resource to 708.6 million tonnes. The results strengthen the proposed ISR pathway, but the decisive test remains field-scale recovery and process consistency.